Plasmodium falciparum malaria 恶性疟疾 ; 恶性疟
plasmodium falciparum infected 恶性疟原虫感染
plasmodium falciparum pf 恶性疟原虫
plasmodium falciparum merozoite 疟原虫裂殖子
plasmodium falciparum chimeric protein 恶性疟原虫融合抗原
EBA-175 of Plasmodium falciparum 恶性疟原虫EBA
plasmodium falciparum-infected erythrocytes 红细胞感染恶性疟原虫
AIM: To assess the sensitivity of Plasmodium falciparum to antimalarials.
目的:了解恶性疟原虫对各种常用抗疟药的敏感性,以指导合理应用抗疟药。
参考来源 - 我国恶性疟原虫对抗疟药敏感性的现状Objective:1. To modify coding sequence of a single chain antibody(2A10) against circumsporozoite protein(CSP) of Plasmodium falciparum and construct fusion gene Cecrop-m2A10.2.
目的:1.对鼠源性恶性疟原虫环子孢子蛋白单链抗体2A10基因进行改造,构建融合基因Cecrop-m2A10。
参考来源 - Cecrop·2,447,543篇论文数据,部分数据来源于NoteExpress
以上来源于: WordNet
Plasmodium falciparum and Plasmodium vivax are the most common.
恶性疟和间日疟最常见。
Conclusion Naphthoquine phosphate is effective for the treatment of patients with Plasmodium falciparum malaria.
结论:磷酸萘酚喹治疗恶性疟疾具有良好的效果。
Objective To explore factors influencing the results of in vitro microtest for drug sensitivity of Plasmodium falciparum (Pf).
目的探讨体外微量法测定恶性疟原虫对抗疟药敏感性的影响因素。
应用推荐